CURT R. HARTMAN
Chair of the Board, President, and Chief Executive Officer
Curt R. Hartman is the Chair of the Board, President, and Chief Executive Officer of CONMED Corporation. He was appointed to the Board of Directors of CONMED on March 1, 2014, assumed the Interim CEO role on July 22, 2014, and became the full-time President and CEO on November 9, 2014. Prior to CONMED, he had a 22-year career at Stryker Corporation, a publicly-traded large-cap medical device company, from 1990 through February 2013.
During his tenure with Stryker, he served as Interim Chief Executive Officer from February 2012 to October 2012 and as Vice President and Chief Financial Officer from April 2009 to October 2012. Mr. Hartman initially joined Stryker as a Manufacturing Engineer. He subsequently held roles of increasing responsibility to include Unit Supervisor, Production Unit Manager, Director of Information Technology, National Accounts Director and Vice President, General Manager, and Global President of the Instruments Division.
Mr. Hartman has a Bachelor of Science degree in Aerospace Engineering from the University of Michigan and holds a Harvard AMP Program Certificate from Harvard Business School. He also has completed the Stryker Advanced Leadership Program at Harvard Business School.
TERENCE M. BERGÉ
Vice President, Corporate Controller
Terence Bergé joined CONMED in 1998 as Assistant Corporate Controller and served as the Company’s Treasurer from 2008 through 2015. In 2013, Mr. Berge’s title was changed to Corporate Vice President, Treasurer and Assistant Controller. In 2015, he was promoted to Vice President, Corporate Controller. Prior to joining CONMED, Mr. Berge was employed by Pricewaterhouse LLP from 1991 through 1998 where he served most recently as an audit manager. He is a certified public accountant and holds a B.S. in Accounting from the State University of New York at Oswego.
PATRICK J. BEYER
President, International and Global Orthopedics
Patrick Beyer joined as President of CONMED International in December 2014. Prior to joining CONMED, Mr. Beyer served as CEO of ICNet, a privately held infectious control software company from 2010 to 2014, when the company was sold. Prior to this, Mr. Beyer spent 21 years at Stryker Corporation where he led Stryker Europe from 2005-2009, Stryker UK, South Africa ,and Ireland from 2002 to 2005, and Stryker Medical from 1999 to 2002. Mr. Beyer graduated from Kalamazoo College with a BA in Economics, Western Michigan University with an MBA in Finance and Harvard Business School’s Advanced Management Program.
HEATHER L. COHEN
Executive Vice President, Human Resources
Heather Cohen joined CONMED in 2001 as Associate Counsel, served as Deputy General Counsel from 2002 to 2015, and held the Company's Secretary role from 2008-2018. In 2008, Ms. Cohen was also named the Vice President of Corporate Human Resources. In 2013, Ms. Cohen’s title was changed to Executive Vice President, Human Resources, Deputy General Counsel and Secretary, and in April 2015 her title changed to Executive Vice President, Human Resources & Secretary. Prior to joining CONMED, Ms. Cohen was an Associate Attorney with the law firm Getnick Livingston Atkinson Gigliotti & Priore, LLP from 1998 to 2001. Ms. Cohen holds a BA in Political Science and Education from Colgate University and a JD from Emory University.
Executive Vice President, Information Technology & CIO
Shanna Cotti-Osmanski joined CONMED in 2020. Prior to CONMED, she was employed by Charles River Laboratories, Inc, from 2006 through 2020, where she served the last five years as Sr. VP, Information Technology & CIO. Prior, she was a Sr. Consultant for Microsoft Corporation from 2001 through 2006 and was also a Sr. Consultant for Idea Integration (Actium@Modis Solutions) from 1998 through 2001. Ms. Cotti has a BS in Management Information Systems from Pennsylvania State University, The Behrend College.
Vice President, International
In June 2022, Stéphan Epinette was named Vice President of CONMED’s International division. He oversees all commercial operations outside the US across EMEA, Asia Pacific, Canada, and Latin America. Stéphan joined CONMED in October 2015 as Vice President and General Manager of our EMEA region before being given additional responsibilities for the Asia Pacific region in December 2019. Prior to CONMED, Stéphan worked at Tornier and Stryker where he held a variety of positions in sales, marketing, and management. This includes Senior Vice President Commercial Operations International, Marketing Director MedSurg EMEA, Assistant to the EMEA President, Director Business Development & Market Intelligence EMEA, and Business Unit Director MedSurg France.
TODD W. GARNER
Executive Vice President and Chief Financial Officer
Todd W. Garner was appointed CONMED Corporation’s Executive Vice President and Chief Financial Officer in January 2018. Prior to joining CONMED, Mr. Garner worked for C.R. Bard, Inc. from 2003 through 2017 in several roles, including Vice President – Investor Relations, Vice President, Controller (Division Chief Financial Officer) for its Medical division, Director of Financial Reporting and the Controller of the Reynosa Mexico Operations. Prior to working at C.R. Bard, Inc., Mr. Garner was the acting CFO and Controller at Echopass Corporation (currently Genesys Corporation), the Controller and Value Planning Manager at Futura Industries, Corp., Accounting Manager at Excel Communications and Accounting Coordinator at Verizon. Mr. Garner began his career with Arthur Andersen LLP.
Mr. Garner holds a M.B.A. from the University of Texas – Rio Grande Valley, and a B.S. in accounting from Brigham Young University. Mr. Garner is also a Certified Public Accountant.
DANIEL S. JONAS, ESQ.
Executive Vice President, Legal Affairs, General Counsel & Secretary
Daniel Jonas joined CONMED as General Counsel in 1998 and became the Vice President, Legal Affairs in 1999. In 2013, Mr. Jonas’ title was changed to Executive Vice President, Legal Affairs & General Counsel. In 2018, Mr. Jonas assumed the role of Secretary. Prior to his employment with CONMED, Mr. Jonas was a partner with the law firm of Harter, Secrest, & Emery, LLP in Syracuse in 1998, having joined the firm as an Associate Attorney in 1995. Mr. Jonas holds an A.B. in Classics (Latin) from Brown University and a J.D. from the University of Pennsylvania Law School.
Vice President, Quality Assurance & Regulatory Affairs
Brent Lalomia joined CONMED in June 2019. Prior, he had a 23-year history at Stryker Corporation. Most recently he served as the VP, Quality Assurance and Facilities Management of Stryker Instruments Division from 2014 to 2019. Prior to this, he held various positions in Strategy deployment from 2009 to 2014, Research & Development from 2004 to 2009, and Manufacturing. Mr. Lalomia holds a BS in Mechanical Engineering from Western Michigan University and an MBA from the University of Notre Dame.
Vice President & General Manager, US Orthopedics
Nathan Miersma joined CONMED in January 2022. Prior to joining, Mr. Miersma spent 19 years at Stryker Corporation in RAQA, Operations, Marketing, Sales, Strategic Sales, and most recently leading Stryker’s ASC business. He has a BA in Sociology from Western Michigan University, an MBA from Colorado Technical University, and has completed executive education courses at Harvard University and The University of Chicago Booth School of Business. Mr. Miersma is also an Army veteran, serving as a Platoon Leader in Iraq in 2004-2005 and as a Company Commander in Iraq in 2008.
SARAH M. OLIKER , ESQ.
Vice President, Assistant General Counsel
Sarah M. Oliker, Esq. joined CONMED in 2014 as Assistant General Counsel. She became Assistant General Counsel and Assistant Secretary in 2018, and was promoted to her current VP role in 2021. Prior to CONMED, she was Senior Counsel for ProCure Treatment Centers, Inc. in New York City, having previously spent five years with Epstein Becker & Green in its Health Care & Life Sciences group based in Washington, D.C. Ms. Oliker holds a bachelor’s degree from Colgate University and a J.D. degree from Syracuse University College of Law.
Treasurer and Vice President, Tax
Johonna Pelletier joined the CONMED in 2005 as Tax Director and was promoted to her current role in 2015. Prior to CONMED, she was employed by PricewaterhouseCoopers LLP as a tax senior manager. She is a certified public accountant and graduated with a B.S. degree in Accounting from Le Moyne College.
STANLEY W. (BILL) PETERS
President, Advanced Surgical and Advanced Endoscopic Technologies
Bill Peters joined CONMED in 2015. Prior to joining, Mr. Peters served as Director of Sales for Mako Surgical Corporation from 2012 to 2014, during which Mako was purchased by Stryker Corporation in December 2013. Prior to this, he served as an executive with EndoGastric Solutions, and in sales leadership roles at Intuitive Surgical and Stryker Corporation. He graduated from Ohio University with a B.B.A. degree in Finance.
JACLYN (JACKIE) PETERSON
Vice President, Manufacturing and Advanced Engineering
Jackie Peterson joined CONMED in 2021. Prior to joining, she was employed by Medtronic for 11 years, where she last served as Senior Director, Global Operations Strategy and Program Management. Prior to Medtronic, Jackie held roles of increasing responsibility at 3M Company in the Drug Delivery Systems, Healthcare, and Occupational Health and Environmental Safety Divisions. She has a M.S. in Management of Technology from the University of Minnesota and a B.S. in Mechanical Engineering from the University of Texas.
PETER K. SHAGORY
Executive Vice President, Strategy and Corporate Development
Peter Shagory joined CONMED in 2015. He has more than 20 years of experience in healthcare venture investing and mergers and acquisitions through his previous venture capital, investment banking, and corporate roles. Prior to joining CONMED, Mr. Shagory led the strategy and business development efforts for Cardinal Health's Medical Products Group within the Medical Segment, where he played a key role in Cardinal Health’s entry into the interventional cardiovascular and the advanced wound care categories. Prior to that, Mr. Shagory led the healthcare and life sciences investment effort at Baird Venture Partners, focusing on medical technology, research tools, and diagnostics. He earned an MBA from Dartmouth’s Tuck School of Business and a B.S. in Finance from Miami University in Oxford, Ohio.
Vice President, Sales, Marketing, and Innovation
A graduate of the University of Tennessee, Alan Taylor has been in the medical device industry for over 30 years. Mr. Taylor spent 20 years at Wright Medical, where he ran the Extremities division for six years - making it the basis for Wright’s dominance of the market. Since 2011, he has been involved in several extremity start-ups, including Nexa Extremities, MemoMetal, and Solana Surgical when he held General Manager, President, and Chief Executive Officer positions. Most recently, Mr. Taylor was President and CEO of In2Bones when it merged with CONMED in June 2022.
CURT R. HARTMAN, CHAIR
Curt R. Hartman has served as President & Chief Executive Officer of the Company since November 9, 2014 after serving as Interim Chief Executive Officer of the Company from July 2014 to November 2014, and as a Director of the Company since March 2014.
Mr. Hartman’s qualifications for election to CONMED’s Board include his vital role as both Chief Executive Officer and Interim Chief Executive Officer of the Company, as well as his experience as a former CFO of a publicly-traded medical device company in the orthopedic space. He offers industry experience from a commercial, operational and financial perspective. Mr. Hartman was initially appointed to the Company’s Board of Directors pursuant to an agreement, now expired, between the Company and Coppersmith Capital Management, LLC and certain of its affiliates.
David Bronson has served as a Director of the Company since July 2015. Mr. Bronson served as Executive Vice President and Chief Financial Officer of PSS World Medical, Inc. from 2002 until it was acquired by McKesson Corp in 2013. Prior to that, he was Chief Financial Officer of Digineer, Inc. from 2001 to 2002 and of VWR Scientific Products from 1995 to 1999, when it was acquired by Merck KGaA. Mr. Bronson previously spent 15 years at Baxter Healthcare, Inc., where he held various senior financial executive positions. He was a Director and a member of the Audit Committee of Labsco, Inc. until 2016 and was a Director and Audit Committee Chair of AxelaCare, Inc. through November 2015.
The Board of Directors has determined that Mr. Bronson is independent and that he is an audit committee financial expert, within the meaning of the rules of the Securities and Exchange Commission. Mr. Bronson’s qualifications for election to CONMED’s Board include his extensive experience as a Chief Financial Officer generally, and in the health-care industry in particular, as well as his financial and accounting expertise acquired through his prior positions. His exposure to, and familiarity with, health care services matters provides an important perspective to the Board. He has the ability and willingness to serve on a Board, and the correct fit to work in a collegial manner with the other directors.
Brian P. Concannon has served as a Director of the Company since July 2013. Mr. Concannon served as President and CEO of Haemonetics Corporation (NYSE: HAE), a blood management technologies and services company headquartered in Braintree, Massachusetts, from April 2009 to October 2015. He joined Haemonetics in 2003 and served in various roles, including President, Global Markets in 2006 and the Chief Operating Officer in 2007-2009. In April 2009, Mr. Concannon was also elected to the Haemonetics board of directors. Prior, Mr. Concannon was the President, Northeast Region for Cardinal Health Medical Products and Services, where he was employed since 1998. From 1985 to 1998, he was employed by American Hospital Supply Corporation, Baxter Healthcare Corp, and Allegiance Healthcare in a series of sales and operations management positions of increasing responsibility. Mr. Concannon is a member of the board of directors of South Shore Health since January 2014 and was elected Vice-Chair in January 2017. Mr. Concannon was also appointed as the Civilian Aide to the Secretary of the Army for Massachusetts in October 2017.
The Board of Directors has determined that Mr. Concannon is independent within the meaning of the rules of the Securities and Exchange Commission. Mr. Concannon’s qualifications for election to CONMED’s Board include his experience as a former CEO and director of a publicly-traded medical device company, and the former president of a distribution company. Mr. Concannon offers industry experience from a sales and marketing perspective. He has the ability and willingness to serve on a Board, and the correct fit to work in a collegial manner with the other directors.
Laverne Council is the Chief Executive Officer of Emerald One, LLC, a consulting company focused on helping business and technology organizations transform through digital change. She is the former National Managing Principal, Enterprise Technology Strategy & Innovation for Grant Thornton LLP, serving in that role from December 2017 through November 2019. Prior, she served as the Assistant Secretary for Information & Technology and Chief Information Officer for the United States Department of Veterans Affairs from 2015 through 2017, leading the largest centralized technology organization in the federal government. Ms. Council was the Chief Executive Officer of Council Advisory Services, LLC from 2012 through 2015 and served as the Corporate Vice President and Global Chief Information Officer for Johnson & Johnson from 2006 through 2011. Prior, she served in a number of roles of increasing responsibility at DELL, Inc., most recently as the Global Vice President Information Technology, Global Business Solutions and Development Services.
The Board of Directors has determined that Ms. Council is independent within the meaning of the rules of the Securities and Exchange Commission and under the standards of the NASDAQ Stock Market. She is a recognized global operations and information technology strategist and change agent.
CHARLES M. FARKAS
Charles M. Farkas has served as a Director of the Company since July 2014. Mr. Farkas has spent the past 38 years at Bain & Company. He became an Advisory Partner effective July 1, 2015. Prior to this, Mr. Farkas was a Senior Partner at Bain & Company, served as the Global Co-Head of Bain's Healthcare Practice and advised leading medical technology and pharmaceutical companies in the United States, Europe, and Asia. He also advised academic medical centers and provider organizations in the United States. Mr. Farkas has served as the managing director of Bain Canada and as the global leader of Bain & Company's Financial Services practice. Mr. Farkas is also on the Board of Harvard Medical School and the John A. Hartford Foundation and is a Corporator of Partners Healthcare. He is a special advisor to Altamont Capital Partners to support their investments in small-cap healthcare businesses.
The Board of Directors has determined that Mr. Farkas is independent within the meaning of the rules of the Securities and Exchange Commission. Mr. Farkas’ qualifications for election to CONMED’s Board include his almost 40 years working in healthcare in the US and around the world. Mr. Farkas is a highly-respected leader with a strong academic background, and he offers the other directors new strategic and governance perspectives, drawing on his vast experience inside and outside the healthcare industry. Mr. Farkas was initially appointed to the Company’s Board of Directors pursuant to an agreement, now expired, between the Company and Coppersmith Capital Management, LLC (“Coppersmith Capital”) and certain of its affiliates.
MARTHA GOLDBERG ARONSON, LEAD INDEPENDENT DIRECTOR
Martha Goldberg Aronson was appointed to the Board on February 23, 2016. Ms. Goldberg Aronson has had responsibility for global health care businesses ranging in size from $500 million to $1.0 billion. She was the Executive Vice President and President of Global Healthcare for Ecolab, Inc. (NYSE: ECL) from 2012 through 2015, having previously served as the Senior Vice President and President – North America for Hill-Rom Holdings, Inc. (NYSE: HRC) from 2010-2012. Prior to that, Ms. Goldberg Aronson was the Senior Vice President and Chief Talent Officer for Medtronic, Inc. (NYSE: MDT), having held various prior general management positions within Medtronic, both in the United States and Internationally. Ms. Goldberg Aronson also serves on the board of directors of Methode Electronics, Inc. (NYSE: MEI), Cardiovascular Systems, Inc. (NASDAQ: CSII) and Clinical Innovations, LLC.
The Board of Directors has determined that Ms. Goldberg Aronson is independent within the meaning of the rules of the Securities and Exchange Commission. Ms. Goldberg Aronson’s qualifications for election to CONMED’s Board include her extensive experience in the global healthcare markets, including leadership roles within medical device companies, including her experience in marketing and talent development. She has the ability and willingness to serve on a Board, and the correct fit to work in a collegial manner with the other directors.
JEROME J. LANDE
Jerome J. Lande has served on the Board since March 2014. As of April 4, 2016, Mr. Lande became Head of Special Situations for Scopia Capital Management L.P. (“Scopia”) and as of January 1, 2018 also became a Partner of Scopia. Prior to Scopia, Mr. Lande was the Managing Partner of Coppersmith Capital, which he co-founded in April 2012. Previously, Mr. Lande was a partner at MCM Capital Management, LLC (“MCM”), from January 2006 until February 2012, and served as an Executive Vice President at MCM from January 2005 until he left the company. He served as a Vice President of MCM from February 2002 to January 2005 and as an Associate from January 1999 to February 2002. Mr. Lande served as Corporate Development Officer of Key Components, Inc., a global diversified industrial manufacturer that was formerly an SEC reporting company, from January 1999 until its acquisition by Actuant Corporation in February 2004. Mr. Lande also serves on the Board of Directors, Audit and Finance Committee for Itron, Inc. (NASDAQ: ITRI).
The Board of Directors has determined that Mr. Lande is independent within the meaning of the rules of the Securities and Exchange Commission. Mr. Lande’s qualifications for election to CONMED’s Board include his experience as an investor in CONMED and in other stocks. He offers the perspective of a professional investor, with over 20 years of experience investing in healthcare companies in general and medical device companies in particular. He brings a distinct focus on governance, capital markets and shareholder matters to the Board. Mr. Lande was initially appointed to the Company’s Board of Directors pursuant to an agreement, now expired, between the Company and Coppersmith Capital Management, LLC and certain of its affiliates.
BARBARA J. SCHWARZENTRAUB
Barbara J. Schwarzentraub has been with Caterpillar, Inc. since 1990 and currently serves as a Director and Divisional Chief Financial Officer for Global Information Services Division. From 2016 through 2017, Ms. Schwarzentraub was the Director of Caterpillar’s Global Component Manufacturing and Supply Chain, having previously served as the Director of Caterpillar’s Parts Distribution and Vice President of Caterpillar Logistics Services Inc. from 2010 through 2016. She also served as the Director of Global Finance Transformation from 2006 through 2010. Prior to these roles, Ms. Schwarzentraub held a number of positions of increasing responsibility within Caterpillar, including Six Sigma Deployment Director, Manager of FP&A, Process Improvement Manager, and various accounting positions.
The Board of Directors has determined that Ms. Schwarzentraub is independent within the meaning of the rules of the Securities and Exchange Commission.
JOHN L. WORKMAN
John L. Workman was appointed to the Board in July 2015. Mr. Workman served as Chief Executive Officer of Omnicare, Inc. from 2012 to 2014, as President and Chief Financial Officer from 2011 to 2012, and as Executive Vice President and Chief Financial Officer from 2009 to 2010. At Omnicare, he improved operating efficiencies through a focus on customer service and returned the company to growth and stability. From 2004 to 2009, he was Chief Financial Officer of HealthSouth Corporation (now Encompass Health Corporation). Prior to HealthSouth, Mr. Workman served as Chief Executive Officer of U.S. Can Corporation, where he implemented successful cost reduction and lean manufacturing programs and led a turnaround of the company’s European operations. Mr. Workman started his career at KPMG, where he was a partner from 1981 to 1984. He is currently Chairman of the Board and Audit Committee Chair of Agiliti, Inc. (formerly Universal Hospital Services), a company owned by a private equity fund, and a Director and Audit Committee Chair of Federal Signal Corp (NYSE: FSS). He also served on the Board of Care Capital Properties from August 2016 until its merger with Sabra Health Care REIT in August 2017.
The Board of Directors has determined that Mr. Workman is independent and that he is an audit committee financial expert, within the meaning of the rules of the Securities and Exchange Commission. Mr. Workman’s qualifications for election to CONMED’s Board include his extensive experience as a Chief Financial Officer generally, and in the healthcare industry in particular, as well as his financial and accounting expertise acquired through his experience as a partner with KPMG. His exposure to, and familiarity with, health care services matters and capital structure issues provides valuable insights and perspectives to the Board. He has the ability and willingness to serve on a Board, and the correct fit to work in a collegial manner with the other directors.
BARBARA J. SCHWARZENTRAUB, CHAIR
DR. JOHN L. WORKMAN
BRIAN CONCANNON, CHAIR
JEROME L. LANDE
DAVID BRONSON, CHAIR
MARTHA GOLDBERG ARONSON
JEROME J. LANDE, CHAIR
DR. JOHN L. WORKMAN
Interested parties may communicate with the Board of Directors by sending correspondence addressed to the Board of Directors, c/o General Counsel, CONMED Corporation, 11311 Concept Boulevard, Largo FL 33773, or by email to the General Counsel with the subject line listed as ‘Communication to Board of Directors.’ We cannot promise that all communications will receive a response, although they will be reviewed.